Carnegie acted as financial adviser to Recipharm in the acquisition of Lusomedicamenta. Recipharm provides contract manufacturing and development services for other pharmaceutical companies. Lusomedicamenta is primarily a CDMO specialised in the development and manufacture of solid, liquid and semi-solid dose forms as well as sterile ophthalmic products. November 2014.